INTRODUCTION
The mechanism of urea reabsorption by the renal tubule has been a problem of major interest since the studies of Shannon (1, 2) , who concluded that urea reabsorption in the dog kidney is a passive process, dependent on glomerular filtration and the rate of tubular reabsorption of water. Support for this view was provided by the observation that acetamide and thiourea movement across toad skin (3) and urea movement across toad bladder (4) This work was presented in part at the 5th International Congress of Nephrology, Mexico City, October 1972.
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Received for publication 30 November 1972 and in revised form 18 January 1973. appeared to be accelerated in the direction of net water flow. This "solvent drag" effect not only suggested that urea and other small molecules move passively across the cell membrane, but that true aqueous channels exist in the membrane, large enough to permit water-solute interaction.
There is however, abundant evidence that urea movement is more than a passive process, influenced primarily by water flow. Active urea secretion by the frog kidney has been clearly demonstrated by Forster (5) . Under conditions of protein depletion, a number of species appear able to reabsorb urea from tubular urine against a concentration gradient (6-10). Goldberg, Wojtczak, and Ramirez (11) have described uphill urea movement in the dog renal medulla. Intrarenal control of urea reabsorption by the elasmobranch kidney occurs independent of the filtered load of urea, and against a concentration gradient (12, 13) . While questions remain about the exact nature of the process involved (14) , it appears that under certain conditions and in some species, carrier-mediated transport may account for a significant fraction of urea reabsorption.
In the present paper, we have reexamined the movement of amides and other small molecules across the toad bladder, and the relationship of the movement of these solutes to water flow. These studies were prompted by two recent observations: (a) the solvent drag effect on amide diffusion across the bladder is abolished when the bathing medium is effectively stirred (15) ; (b) Macey and Farmer have reported that phloretin inhibits urea movement across the erythrocyte without decreasing osmotic water flow (16) . We have found that 10-' M phloretin, when present in the luminal bathing medium of the toad bladder, virtually abolishes urea movement, with no inhibition of water flow or active sodium transport. This selectivity of drug effect is seen both in the presence and absence of vasopressin. The inhibitory action of phloretin extends to amides in general, and to formaldehyde and thiourea. Ethanol and ethylene glycol, on the other hand, are not affected. We would conclude that the movement of certain solutes, notably the amides, is independent of water flow and active sodium transport, and may be mediated by a vasopressin-sensitive carrier in the luminal membrane.
METHODS
Female toads (National Reagents, Bridgeport, Conn.) were doubly pithed, and glass bungs tied into both bladders in situ. The bladders were removed, and filled with either full strength glucose-free phosphate-buffered Ringer's solution (120 mM Na', 4.0 mM K+, 0.5 mM Ca+', 116 mM Cl-, 1.0 mM H2P04-, 4.0 mM HP04-, pH 7.4, 230 mosm/kg H20); or, when osmotic water flow was to be determined, with Ringer's diluted 1:10 with distilled water. The bladders were washed inside and out three times with fresh Ringer's to remove any endogenous vasopressin. They were finally refilled with 5 ml of Ringer's or diluted Ringer's containing the isotope to be tested, and, in the test bladder, a sufficient volume of phloretin (K & K Laboratories, Inc., Plainview, N. Y.) dissolved in ethanol to achieve the desired phloretin concentration. The control bladder contained the isotope and ethanol alone. The final ethanol concentration within the bags was 0.5%o or less; the surface area of the bags was 14.1 cm2. The bladders were then suspended in 30-35 ml of Ringer's solution stirred by a magnetic stirrer, and aerated by compressed air. Stirring was not provided inside the bag, reducing to some extent Ktransurea in the control bladders. The permeability coefficient (Ktrans) of the isotopic species was determined by sampling the inner and outer bathing medium at timed intervals; samples were pipetted into Bray's solution and counted in a Tri-Carb liquid scintillation counter (Packard Instrument Co., La Grange, Ill.). Water movement was determined by carefully blotting the bags and weighing them (17) on a Mettler B-6 balance (Mettler Instrument Corp., Hightstown, N. J.). Short-circuit current was determined by the method of Ussing and Zerahn (18) , using a divided Lucite chamber in which onehalf of the bladder served as a control for the test half (19) . all experiments, results obtained in the test bladder were compared with control bladders by the method of paired analysis (20) .
RESULTS
Effect of phloretin on water and urea movement. The effect of 10-' M phloretin on osmotic water flow and Ktransurea is shown in Fig. 1 . Paired bladder halves, filled with 1/10 Ringer's solution, were used. The test bladder (right-hand panel) had 10' M phloretin in 0.5% ethanol in the luminal bathing medium; the untreated bladder had 0.5% ethanol alone. When vasopressin was added to the untreated bladder, the usual sharp incrase in net water flow and Ktransurea was seen. In the presence of phloretin, water flow was unimpaired; there was, however, a significant reduction in Ktransurea both before and following vasopressin. An increase in Ktransurea following vasopressin was still apparent in the phloretin-treated bladder.
Effect of varying concentrations of phloretin. The effect of varying luminal concentrations of phloretin on water and urea movement following vasopressin is shown in Fig. 2 . 10' M phloretin was without effect on urea movement, while 10' M phloretin produced a small but significant decrease in Ktransurea compared with the untreated control. Urea permeability was maximally inhibited at 10' M phloretin; higher phloretin concentrations had no further effect. Water movement, on the other hand, was unimpaired up to and including 2.5 X 10' M phloretin; at 5 X 10 M, water movement dropped significantly to approximately 50% of control. There was a prompt and symmetrical fall in Ktranurea in both directions, and only a small increase in Ktrans following vasopressin (Fig. 3) .
Effect of phloretin on diffusion of other molecules. The effect of 10' M phloretin on the movement of other amides and non-amides was determined, using the same protocol employed for the urea studies. All molecules studied were those whose permeability is increased by vasopressin. The results are shown in Tables I and II . Phloretin (Table I ) significantly decreased the permeability of acetamide and propionamide, both in the absence of vasopressin (period I) and following vasopressin (periods II and III). As in the case of urea, there was an increase in the Ktran. of the phloretin treated bladders following vasopressin, but the values were considerably below those of the untreated controls. The inhibitory effect of phloretin was not restricted to the amides, however; there was a significant inhibition in Ktranuformaldehyde, apparent in both postvasopressin periods, and a small but significant reduction in period III of Ktra.thiourea.' Table II lists the molecules whose permeability was unaffected by phloretin. These include water, ethanol, and ethylene glycol. Phloretin also failed to depress net sodium transport (see below). ' The appearance of a small, but definite vasopressin effect on Ktranathiourea was unexpected, and can be attributed to the improved method of determining permeabilities, in which the "edge effect" is minimized (see Discussion). Effect on active sodium transport. Fig. 4 shows the mean values for short-circuit current in four experiments in which 10-' M phloretin in ethanol was added to the luminal bathing medium of one-half of a divided Lucite chamber, and ethanol alone was added to the luminal medium of the other half. The addition of these agents followed a control period of 30 min. There was no reduction in short-circuit current folowing phloretin; indeed, there was a small, but consistent increase over the untreated bladder. Ktransurea, determined simultaneously in the chamber, showed the usual inhibition by phloretin.
40 minutes after the addition of phloretin, vasopressin was added to the serosal medium of both half-chambers. The increase in short-circuit current in the untreated bladder exceeded that in the phloretin-treated bladder in two of the four experiments; in the other two, the increases were identical. In view of the inconsistency of this finding, and the possibility that enough phloretin had accumulated within the epithelial cells in the course of the experiment to depress active sodium transport (Fig. 5) .
Effect of phloretin on the serosal side. The effect of 10-' M phloretin in the serosal rather than the luminal bathing medium was determined in six paired experiments. The findings for osmotic flow and for Ktransurea were the same as for the luminal administration of phloretin: vasopressin-stimulated water flow was unimpaired (93±15% of control values), while Ktran.urea was significantly depressed, both in the absence of vasopressin (68±10% of control) and following vasopressin (64±9% of control). The inhibitory effect of serosal phloretin on Kt,.anurea following vasopressin was not as great as that of luminal phloretin; in four paired experiments, AKtrans (serosal-luminal phloretin) was 58±16 (SE) X 10O7cm-s' (P<0.05).
The effect of serosal phloretin on active sodium transport differed significantly from its luminal action: there was a consistent reduction in short-circuit current both in the absence and presence of vasopressin (Fig. 6) .
Reversibility of the phloretin effect. The extent to which the inhibitory action of phloretin on Ktransurea could be reversed was determined by exposing one of a pair of bladders to 10' M phloretin (luminal side); phloretin was then removed by three serial washouts of the contents of the bag with phloretin-free Ringer's containing 0.5% ethanol. The control bag (no exposure to phloretin) was subjected to the same washout procedure. Fig. 7 shows the results of four paired experiments in which phloretin was present in the test bag for one period prior to, and two periods following vasopressin. Phloretin was then washed out of the test bag with vasopressin remaining in the serosal solution. The usual depression of Ktransurea was seen in the presence of phloretin; following washout, Ktransurea rose to the level of the control bladder. The phloretin effect, therefore, was entirely reversed by the washout.
Effect of unlabeled urea. To determine whether phloretin was reducing Ktranurea by simply binding the isotope in the bathing medium and preventing it from penetrating the bladder, the effect of introducing unlabeled urea into the medium was determined. 5 X 10' M unlabeled urea was added to Ringer's solution containing 10 (16) that phloretin inhibited the movement of urea into the erythrocyte without diminishing osmotic flow showed that in the erythrocyte membrane the mechanisms, and possibly the pathways, for water and urea movement were separate. Our findings in the toad bladder confirm and extend these observations. Several features of the action of phloretin on the toad bladder deserve comment. Phloretin inhibits urea movement at a concentration in the luminal bathing medium as low as 10-' M; maximal inhibition (approximately 80%) is at 10' M. Active sodium transport is maintained, both in the absence and presence of vasopressin, when phloretin is present in the luminal medium, but is depressed by phloretin in the serosal medium. The depression of sodium transport probably represents a direct inhibitory action of the drug on the sodium pump, which is believed to be located at the basolateral cell membrane. Phloretin at either surface of the bladder inhibits urea movement, and shows no effect on water movement; the inhibitory effect on Ktransurea, however, is less striking when the drug is on the serosal side. These findings suggest that phloretin acts at a site in the luminal membrane, rather than at an intracellular or basolateral site, and are consistent with earlier evidence that the luminal membrane is the rate-limiting barrier for urea movement across the cell (21) . Phloretin in-pressin may proceed through the same pathway, and that phloretin inhibits this pathway to the same extent before and after vasopressin. It is also apparent that urea transport can be greatly depresed with no accompanying reduction of active sodium transport, indicating that the close correlation between urea and sodium transport reported in the dogfish (24) (Table II) .
The extent to which these non-electrolytes are capable of forming hydrogen bonds may be of importance in determining whether they move through the phloretinsensitive pathway. It is also of interest that ethylene glycol and ethanol are molecules that appear to penetrate human red cells by simple diffusion, rather than facilitated diffusion (25) , and that, as in the toad bladder, phloretin has no effect on the movement of ethylene glycol in the red cell (16) . Thiourea, on the other hand, which is inhibited by phloretin, may be related closely enough to the amides in structure to have an affinity for the amide pathway; there is evidence, for example, that thiourea as well as true amides are actively secreted by the frog renal tubule (26) . However, no evidence exists for an active mucosal to serosal transport system for thiourea in the renal tubule of the shark (13) or of the protein-depleted sheep (13) . While no obvious relationship exists between thiourea structure and transport in the toad bladder, its inclusion in the group of compounds that may be carrier-mediated could explain our earlier finding that thiourea has a reflection coefficient significantly less than 1.0 (27) . Indeed, the observation by Diamond and Wright (28) (4, 21) . The increase in Ktrans is apparent in Table I , and has been confirmed in an independent group of paired studies (Franki, Levine, and Hays, unpublished observations), in which one bladder half received vasopressin and the control half did not. AKtrans (vasopressin-control) was 2.2+0.4 (SE) X 10-7 cm I s'1; P < 0.02. Our failure to detect a vasopressin effect in the earlier experiments was probably due to edge damage associated with the Lucite chambers used in these studies (29, 30) (Table I ). This would be consistent with an action of phloretin at a protein rather than at a lipid site. Handler, Sugita, Preston, and Orloff (32) have reported that cycloheximide and puromycin, inhibitors of protein synthesis, reduce the permeability of the bladder to urea to a relatively greater extent than the permeability to water, again suggesting that a protein component may be involved in vasopressin-stimulated urea movement. In view of the complex structure of membranes, however, and the number of steps outside the membrane involved in the action of vasopressin, neither finding is conclusive. With regard to the location of the non-electrolyte transport pathway, it could be in series with, or parallel to the water pathway. The present studies do not distinguish between these two possibilities.
How phloretin inhibits the movement of non-electrolytes is obscure. The inhibition is easily reversible, making it unlikely that covalent bonding is involved in its action. It also seems unlikely that phloretin acts as a competitive inhibitor of non-electrolyte transport, in view of the extraordinary capacity of the transport system. Phloretin may alter the properties of the transport system at a point other than the amide receptor site; with the limited information now at hand, this would be a reasonable possibility. There is no evidence for either an interference with cell metabolism or a non-specific effect on membrane permeability, since sodium transport and water flow are preserved, and the permeabilities of ethanol and ethylene glycol are unchanged. As in the red cell (33), we have found that the inhibitory effect of phloretin is abolished when the pH of the luminal bathing medium is raised to 9.0. This is the result of a shift from the physiologically active ketonic to the inactive enolic form of the compound (33) .
Phloretin, and the naturally occurring glucoside phlorizin, have both been shown to inhibit transport of a variety of compounds across cell membranes. They both inhibit monosaccharide transport across the cat proximal tubule (34) and the hamster small intestine (35) ; phlorizin is markedly more potent in both preparations. In the human red cell, on the other hand, phloretin is a more potent inhibitor of glucose entry than phlorizin (33) , and also inhibits sodium uptake by the dog red cell (36) . Alvarado (35) , in discussing the mode of action of the two compounds in the small intestine, has suggested that phlorizin competes with glucose and its analogs for a common membrane binding site, while phloretin inhibits sugar transport allosterically at a different, although closely associated binding site. He has proposed a model in which the glucose carrier is assumed to have two different binding sites: one for phenols, to which both phloretin and phlorizin bind, and one for sugars, to which glucose and phlorizin bind. The existence of two binding sites for phlorizin in the model could account for the finding that phlorizin has a higher affinity for the carrier than glucose, and is a competitive inhibitor of intestinal sugar transport (35) . While phloretin may occupy an allosteric site in the intestinal and renal tubular glucose carriers, there is evidence that it is a competitive inhibitor of erythrocyte glucose transport (37) 
